Patents by Inventor Jeanette Thorbecke

Jeanette Thorbecke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Patent number: 8142779
    Abstract: Therapeutic uses of inhibitors of the lymphotoxin pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: March 27, 2012
    Assignees: Biogen Idec MA Inc., New York University
    Inventors: Jeffrey Browning, Jeanette Thorbecke, Vincent Tsiagbe
  • TREATMENT OF FOLLICULAR LYMPHOMAS USING INHIBITORS OF THE LT PATHWAY
    Publication number: 20100136000
    Abstract: Therapeutic uses of inhibitors of the lymphotoxin pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Application
    Filed: October 13, 2009
    Publication date: June 3, 2010
    Applicants: NEW YORK UNIVERSITY, BIOGEN IDEC MA INC.
    Inventors: Jeffrey BROWNING, Jeanette THORBECKE, Vincent TSIAGBE
  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Patent number: 7618933
    Abstract: Therapeutic uses of inhibitors of the Lymphotoxin Pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: November 17, 2009
    Assignees: New York University, Biogen Idec MA Inc.
    Inventors: Jeffrey L. Browning, Jeanette Thorbecke, Vincent Tsiagbe
  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Publication number: 20060280722
    Abstract: Therapeutic uses of inhibitors of the Lymphotoxin Pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Application
    Filed: April 25, 2006
    Publication date: December 14, 2006
    Applicants: Biogen Idec MA, Inc., New York University
    Inventors: Jeffrey Browning, Jeanette Thorbecke, Vincent Tsiagbe
  • Treatment of follicular lymphomas using inhibitors of the LT pathway
    Patent number: 7060667
    Abstract: Therapeutic uses of inhibitors of the Lymphotoxin Pathway to treat tumors, specifically to treat follicular lymphomas.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: June 13, 2006
    Assignees: Biogen Idec MA, Inc., New York University
    Inventors: Jeffrey Browning, Jeanette Thorbecke, Vincent Tsiagbe
  • Method for augmenting immune response
    Patent number: 4937071
    Abstract: A method for enhancing the ability for humoral immune response in a mammal comprising: exposing lymphocytes histocompatible with the lymphocytes of said mammal to the presence of delta-immunoglobulin at a concentration higher than that at which said lymphocytes would have been exposed while in the lymph or bloodstream of said mammal; and introducing said lymphocytes to the bloodstream or lymph of said mammal.
    Type: Grant
    Filed: December 29, 1987
    Date of Patent: June 26, 1990
    Assignee: New York University
    Inventors: Richard F. Cioco, G. Jeanette Thorbecke
  • Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
    Patent number: 4844895
    Abstract: Compositions and methods for modulating immune responses in mammals comprising immunomodulating-effective amounts of PF4 or a biologically active peptide fragment of platelet factor 4 are disclosed herein. Immunomodulation includes one or more aspects of restoration of suppressed immune responses, inhibition of immune suppression (due to exposure of a mammal of an agent that causes suppressor cell activation) and augmentation of normal immune responses.
    Type: Grant
    Filed: July 30, 1987
    Date of Patent: July 4, 1989
    Assignee: New York University
    Inventors: G. Jeanette Thorbecke, Marjorie B. Zucker
  • Composition containing platelet factor 4 and method for restoring suppressed immune responses
    Patent number: 4702908
    Abstract: Compositions and methods for modulating immune responses in a mammal comprising immunomodulating-effective amounts of platelet factor 4 are disclosed herein. Immunomodulation includes one or more aspects of restoration of suppressed immune responses, inhibition of immune suppression (due to exposure of a mammal of an agent that causes suppressor cell activation) and augmentation of normal immune response.
    Type: Grant
    Filed: November 1, 1985
    Date of Patent: October 27, 1987
    Inventors: G. Jeanette Thorbecke, Marjorie Zucker